KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Gentex (GNTX) Research & Development (2016 - 2025)

Gentex (GNTX) has disclosed Research & Development for 17 consecutive years, with $53.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 13.1% year-over-year to $53.2 million, compared with a TTM value of $203.3 million through Dec 2025, up 12.0%, and an annual FY2025 reading of $203.3 million, up 12.0% over the prior year.
  • Research & Development was $53.2 million for Q4 2025 at Gentex, up from $52.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $53.2 million in Q4 2025 and bottomed at $27.7 million in Q1 2021.
  • Average Research & Development over 5 years is $39.5 million, with a median of $39.1 million recorded in 2023.
  • The sharpest move saw Research & Development decreased 6.63% in 2021, then grew 21.72% in 2024.
  • Year by year, Research & Development stood at $31.3 million in 2021, then rose by 11.61% to $34.9 million in 2022, then increased by 18.89% to $41.5 million in 2023, then rose by 13.31% to $47.1 million in 2024, then grew by 13.1% to $53.2 million in 2025.
  • Business Quant data shows Research & Development for GNTX at $53.2 million in Q4 2025, $52.6 million in Q3 2025, and $51.5 million in Q2 2025.